Navigation Links
The neuroscience of choosing: Can we understand how the brain makes decisions?

Although still a young field, research in "decision neuroscience" has exploded in the last decade, with scientists beginning to decipher what exactly is happening in our brains when we are making choices, whether big or small.

In fact, early findings suggest it is possible to parse out the complexity of thinking into its individual components, and in the process determine how they are integrated as we ponder and decide.

Recently, researchers in decision neuroscience participated in a discussion about their work and the genesis of this cutting-edge field. During the dialogue, they discussed how decision neuroscience hopes to greatly advance our understanding of the brain, and in turn our understanding of mental disorders ranging from depression to schizophrenia.

"For many psychiatric disorders, patients that are symptomatic are frequently making poor decisions about numerous things throughout the day, such as how they handle their anxiety and other emotional states," said C. Daniel Salzman, MD, PhD., Department of Psychiatry and Neuroscience and Kavli Institute for Brain Science, Columbia University School of Medicine. "If you've ever had a friend or family member with depression, you can see they are not making decisions the way they normally do. So there clearly has to be dysfunction in the neurocircuits of psychiatric patients affecting their decisions, and we need to understand this better in order to come up with better treatments for mental disorders."

As pointed out by another participant in the dialogue, this research is already deepening understanding of these disorders.

"Our new knowledge about the cellular and circuit mechanisms of working memory and decision processes in the brain has already had a significant impact on clinical studies of mental illness," said Xiao-Jing Wang, PhD., Department of Neurobiology, Physics and Psychology; Director, Swartz Program in Theoretical Neurobiology; Kavli Institute of Neuroscience, Yale University School of Medicine. "For instance, addiction is fundamentally a problem of making bad choices, resulting from impaired reward signaling and decision-making circuits in the brain. Understanding these circuits has become key to linking genes and molecules with behavior in clinical studies."

Daeyeol Lee, PhD., Department of Neurobiology and Kavli Institute for Neuroscience, Yale University School of Medicine, stated one important goal is understanding the neurobiological basis for individual variability in decision making.

"When people face the same decision, they tend to make different choices," said Lee. "Some of that is due to their different experiences and learning environment. There are also fundamental genetic differences that give rise to different decision making styles. Getting a better understanding of the neurobiological basis for those individual differences in decision making will have enormous implications. It can explain a lot of problems in our society, including differences in the tendency to develop psychiatric illnesses."


Contact: James Cohen
The Kavli Foundation

Related medicine news :

1. Landmark law and neuroscience network expands at Vanderbilt
2. Conference: Improving K-12 education with cutting-edge cognitive neuroscience research
3. New Society for Social Neuroscience to help guide emerging field
4. Yerkes researchers present at 40th Annual Society for Neuroscience Conference
5. Neuroscience research may help patients recover from brain injury
6. University Hospitals Case Medical Centers neuroscience intensive care unit earns Beacon Award
7. Elsevier launches new journal: Developmental Cognitive Neuroscience
8. Scott & White Healthcare receives designation as Neuroscience Center of Excellence
9. Culture wires the brain: A cognitive neuroscience perspective
10. Lord Brain Memorial Lecture is launched in recognizing outstanding contribution to neuroscience
11. University Hospitals Neurological Institute earns Neuroscience Center of Excellence designation
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 10, ... States District Court of Connecticut on behalf of a home health care worker who ... current or former home health care workers employed by Humana, Inc., Humana at Home, ...
(Date:11/25/2015)... ... , ... On November 25, 2015, officials of Narconon Arrowhead , the ... of a new cutting edge recovery program that has been 50 years in the ... alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative behaviors ...
(Date:11/25/2015)... ... , ... SCOTTSDALE, AZ) - Today, Dr. Todd C. ... and non-surgical treatments, announced the expansion of his private practice capabilities with the ... Highly trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Today, ... on our nation’s roadways has dropped below 10,000 for the first time since 2011. ... in 2013. , According to data released by the National Highway Traffic Safety Administration ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... of philanthropic seniors, is resulting in a way for homeless people to have ... Schaumburg have launched a new initiative whereby they are repurposing plastic bags into ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 25, 2015 ... due to repeated failure of IVF cycles. After failure ... was totally dejected and had lost all hopes that she would be able ... Indian miracle child conceived after failure of over 15 ... abroad (UK) before they decided to take one last attempt with ...
(Date:11/24/2015)... SAN CARLOS, Calif. , Nov. 24, ... ), a leader in non-invasive genetic testing ... today announced that it will present at ... Conference in New York on Wednesday, December 2, 2015 at 1:00 p.m. ... discuss the Company,s financial results, business activities ...
(Date:11/24/2015)... /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") ... the first patient has been enrolled in ESSA,s Phase ... metastatic castration-resistant prostate cancer ("mCRPC"). the ... the United States and Canada.  ... trial, ESSA intends to demonstrate the safety, tolerability, maximum ...
Breaking Medicine Technology: